Question 1

What is Apimeds Pharmaceuticals US, Inc. (APUS)'s latest operating income?

Accepted Answer

Apimeds Pharmaceuticals US, Inc. (APUS)'s operating income for FY2025 was -$11.9M, as reported in its SEC filings.

Question 2

How has Apimeds Pharmaceuticals US, Inc. (APUS)'s operating income changed year over year?

Accepted Answer

APUS's operating income went from -$1.3M in FY2024 to -$11.9M in FY2025, a decrease of 834.2%.

Question 3

What is the highest operating income Apimeds Pharmaceuticals US, Inc. (APUS) reported over FY2023–FY2025?

Accepted Answer

The highest reported operating income over FY2023–FY2025 was -$747,436, in FY2023.

Question 4

What years does this operating income history cover?

Accepted Answer

This page shows APUS's operating income for each fiscal year from FY2023 to FY2025, drawn from SEC XBRL filings.

Apimeds Pharmaceuticals US, Inc. (APUS) Operating income 2023–2025

More APUS financial trends